Discounted Cash Flow Rating

Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Strong Sell

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Sell

C

Agile Therapeutics, Inc (AGRX)

Pharmaceutical Preparations

https://www.agiletherapeutics.com

Agile Therapeutics Inc is a women's healthcare company to fulfill the unmet health needs of women. Its product candidates are designed to provide women with contraceptive options. The firm's initial product, Twirla, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin. The Company views its operations and manages its business in one operating and reporting segment, which is the business of commercializing its transdermal patch for use in contraception.

500 COLLEGE ROAD EAST, SUITE 310
PRINCETON, NJ

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

05/23/2014

Market Cap

10,011,525

Shares Outstanding

2,510,000

Weighted SO

2,511,657

Total Employees

N/A

Upcoming Earnings

08/07/2024

Similar Tickers

ASRT --.--%

AMRX --.--%

ACRX --.--%

LFCR --.--%

GHSI --.--%

TKNO --.--%

CYTH --.--%

PTPI --.--%

SHPH --.--%

Beta

1.5820

Last Div

0.0000

Range

0.2-2.63

Chg

-0.0100

Avg Vol

139353

Mkt Cap

10011525

Exch

NASDAQ

Country

US

Phone

609 683 1880

DCF Diff

-0.0854

DCF

0.8053

Div Yield

0.0000

P/S

0.4642

EV Multiple

-0.5598

P/FV

-0.4537

Div Yield %

0.0000

P/E

-0.6269

PEG

-0.0071

Payout

0.0000

Current Ratio

0.5507

Quick Ratio

0.3298

Cash Ratio

0.1086

DSO

77.0006

DIO

269.5621

Op Cycle

346.5627

DPO

769.7852

CCC

-423.2225

Gross Margin

0.6363

Op Margin

-0.6285

Pretax Margin

-0.7352

Net Margin

-0.7352

Eff Tax Rate

-0.0247

ROA

-1.0597

ROE

1.0404

ROCE

1.2033

NI/EBT

1.0000

EBT/EBIT

1.1698

EBIT/Rev

-0.6285

Debt Ratio

0.0193

D/E

-0.0132

LT Debt/Cap

0.0000

Total Debt/Cap

-0.0134

Int Coverage

-90.9732

CF/Debt

-6.7093

Equity Multi

-0.6829

Rec Turnover

4.7402

Pay Turnover

0.4742

Inv Turnover

1.3540

FA Turnover

76.4823

Asset Turnover

1.4414

OCF/Share

-0.2828

FCF/Share

-0.2828

Cash/Share

0.4154

OCF/Sales

-0.0899

FCF/OCF

1.0000

CF Coverage

-6.7093

ST Coverage

-6.7093

CapEx Coverage

0.0000

Div&CapEx Cov

0.0000

P/BV

-0.4537

P/B

-0.4537

P/S

0.4642

P/E

-0.6269

P/FCF

-5.1632

P/OCF

-5.1271

P/CF

-5.1271

PEG

-0.0071

P/S

0.4642

EV Multiple

-0.5598

P/FV

-0.4537

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jan 23, 09:29 The Biden-Harris Administration Announces New Guidance to Enable Expanded Access to All FDA-Approved Contraceptives Without Cost PennyStocks Dec 04, 13:30 Top Penny Stocks To Buy Now? 4 To Watch Under $4

Revenue Product Segmentation